PE20110155A1 - Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- PE20110155A1 PE20110155A1 PE2010000441A PE2010000441A PE20110155A1 PE 20110155 A1 PE20110155 A1 PE 20110155A1 PE 2010000441 A PE2010000441 A PE 2010000441A PE 2010000441 A PE2010000441 A PE 2010000441A PE 20110155 A1 PE20110155 A1 PE 20110155A1
- Authority
- PE
- Peru
- Prior art keywords
- contain
- methyl
- pharmaceutical compositions
- preparation procedure
- carbamate
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- HGVPQJLGBGKLNF-UHFFFAOYSA-N (4-bromophenyl) carbamate Chemical compound NC(=O)OC1=CC=C(Br)C=C1 HGVPQJLGBGKLNF-UHFFFAOYSA-N 0.000 abstract 1
- ANJYDSPMBISEHY-UHFFFAOYSA-N (4-fluorophenyl) carbamate Chemical compound NC(=O)OC1=CC=C(F)C=C1 ANJYDSPMBISEHY-UHFFFAOYSA-N 0.000 abstract 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 201000011240 Frontotemporal dementia Diseases 0.000 abstract 1
- -1 PIPERIDINE PHENYL CARBAMATE DERIVATIVE COMPOUND Chemical class 0.000 abstract 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DERIVADO FENIL CARBAMATO DE PIPERIDINA DE FORMULA (I) DONDE R1 ES H, METILO; R2 ES Br, F, TRIFLUOROMETILO. SON COMPUESTOS PREFERIDOS (4-BROMOFENIL)CARBAMATO DE 1-METIL-PIPERIDIN-3-ILO; (4-FLUOROFENIL)CARBAMATO DE 1-METIL-PIPERIDIN-3-ILO; (4-TRIFLUOROFENIL)CARBAMATO DE 1-METIL-PIPERIDIN-3-ILO; ENTRE OTROS. TAMBIEN SE REFIERE A UN METODO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES UN FACILITADOR MEMOCOGNITIVO UTIL EN EL TRATAMIENTO DE ALZHEIMER, PARKINSON, LA ENFERMEDAD DE PICK, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0903573A FR2948368B1 (fr) | 2009-07-21 | 2009-07-21 | Nouveaux composes piperidiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20110155A1 true PE20110155A1 (es) | 2011-03-19 |
Family
ID=41287719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2010000441A PE20110155A1 (es) | 2009-07-21 | 2010-07-06 | Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20110021569A1 (es) |
| EP (1) | EP2277863A1 (es) |
| JP (1) | JP2011037845A (es) |
| KR (1) | KR20110009065A (es) |
| CN (1) | CN101962355A (es) |
| AP (1) | AP2010005328A0 (es) |
| AR (1) | AR077418A1 (es) |
| AU (1) | AU2010202875A1 (es) |
| BR (1) | BRPI1004309A2 (es) |
| CA (1) | CA2709551A1 (es) |
| CL (1) | CL2010000742A1 (es) |
| CO (1) | CO6240165A1 (es) |
| CR (1) | CR11567A (es) |
| CU (1) | CU20100151A7 (es) |
| EA (1) | EA201001042A1 (es) |
| EC (1) | ECSP10010358A (es) |
| FR (1) | FR2948368B1 (es) |
| IL (1) | IL206884A0 (es) |
| MA (1) | MA32053B1 (es) |
| MX (1) | MX2010007800A (es) |
| MY (1) | MY150546A (es) |
| NZ (1) | NZ586856A (es) |
| PE (1) | PE20110155A1 (es) |
| SG (1) | SG168483A1 (es) |
| SV (1) | SV2010003626A (es) |
| TW (1) | TW201116512A (es) |
| UY (1) | UY32766A (es) |
| WO (1) | WO2011010015A1 (es) |
| ZA (1) | ZA201005204B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9861941B2 (en) | 2011-07-12 | 2018-01-09 | Kraton Polymers U.S. Llc | Modified sulfonated block copolymers and the preparation thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0495071A (ja) * | 1990-08-10 | 1992-03-27 | Kyorin Pharmaceut Co Ltd | カルバミン酸誘導体 |
| JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
| US5300515A (en) * | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
| SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| GB0510140D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B2 |
-
2009
- 2009-07-21 FR FR0903573A patent/FR2948368B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-06 PE PE2010000441A patent/PE20110155A1/es not_active Application Discontinuation
- 2010-07-07 UY UY0001032766A patent/UY32766A/es unknown
- 2010-07-07 AU AU2010202875A patent/AU2010202875A1/en not_active Abandoned
- 2010-07-08 SG SG201004964-1A patent/SG168483A1/en unknown
- 2010-07-08 MY MYPI2010003258 patent/MY150546A/en unknown
- 2010-07-08 IL IL206884A patent/IL206884A0/en unknown
- 2010-07-12 CL CL2010000742A patent/CL2010000742A1/es unknown
- 2010-07-13 CR CR11567A patent/CR11567A/es not_active Application Discontinuation
- 2010-07-14 AP AP2010005328A patent/AP2010005328A0/en unknown
- 2010-07-16 CA CA2709551A patent/CA2709551A1/fr not_active Abandoned
- 2010-07-16 NZ NZ586856A patent/NZ586856A/en not_active IP Right Cessation
- 2010-07-16 MX MX2010007800A patent/MX2010007800A/es not_active Application Discontinuation
- 2010-07-16 CO CO10087231A patent/CO6240165A1/es not_active Application Discontinuation
- 2010-07-19 MA MA33037A patent/MA32053B1/fr unknown
- 2010-07-20 TW TW099123868A patent/TW201116512A/zh unknown
- 2010-07-20 WO PCT/FR2010/000520 patent/WO2011010015A1/fr not_active Ceased
- 2010-07-20 US US12/804,360 patent/US20110021569A1/en not_active Abandoned
- 2010-07-20 BR BRPI1004309-8A patent/BRPI1004309A2/pt not_active Application Discontinuation
- 2010-07-20 EA EA201001042A patent/EA201001042A1/ru unknown
- 2010-07-20 CU CU20100151A patent/CU20100151A7/es unknown
- 2010-07-20 EP EP10290410A patent/EP2277863A1/fr not_active Withdrawn
- 2010-07-20 SV SV2010003626A patent/SV2010003626A/es unknown
- 2010-07-20 AR ARP100102638A patent/AR077418A1/es unknown
- 2010-07-20 JP JP2010162551A patent/JP2011037845A/ja active Pending
- 2010-07-20 EC EC2010010358A patent/ECSP10010358A/es unknown
- 2010-07-21 ZA ZA2010/05204A patent/ZA201005204B/en unknown
- 2010-07-21 KR KR1020100070607A patent/KR20110009065A/ko not_active Ceased
- 2010-07-21 CN CN2010102347263A patent/CN101962355A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CO6240165A1 (es) | 2011-01-20 |
| CR11567A (es) | 2010-10-08 |
| AU2010202875A1 (en) | 2011-02-10 |
| MX2010007800A (es) | 2011-04-20 |
| ZA201005204B (en) | 2011-04-28 |
| UY32766A (es) | 2011-01-31 |
| TW201116512A (en) | 2011-05-16 |
| JP2011037845A (ja) | 2011-02-24 |
| CU20100151A7 (es) | 2012-03-15 |
| ECSP10010358A (es) | 2011-02-28 |
| FR2948368B1 (fr) | 2011-07-22 |
| AP2010005328A0 (en) | 2010-08-31 |
| MA32053B1 (fr) | 2011-02-01 |
| AR077418A1 (es) | 2011-08-24 |
| NZ586856A (en) | 2011-11-25 |
| CA2709551A1 (fr) | 2011-01-21 |
| CL2010000742A1 (es) | 2011-07-08 |
| EP2277863A1 (fr) | 2011-01-26 |
| EA201001042A1 (ru) | 2011-02-28 |
| WO2011010015A1 (fr) | 2011-01-27 |
| US20110021569A1 (en) | 2011-01-27 |
| SV2010003626A (es) | 2011-01-31 |
| IL206884A0 (en) | 2010-12-30 |
| BRPI1004309A2 (pt) | 2012-04-17 |
| MY150546A (en) | 2014-01-30 |
| FR2948368A1 (fr) | 2011-01-28 |
| KR20110009065A (ko) | 2011-01-27 |
| SG168483A1 (en) | 2011-02-28 |
| CN101962355A (zh) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20141682A1 (es) | Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio | |
| PE20110136A1 (es) | Compuestos organicos | |
| PE20090649A1 (es) | DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1 | |
| PE20091834A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona tiofenilo-sustituida como inhibidores de bace-1 y composiciones que los contienen | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| PE20170666A1 (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
| PE20091376A1 (es) | Derivados de fenilamino como moduladores de beta-amiloide | |
| GT200500102A (es) | Compuestos de aril-o-heteroarilamida ortosustituidos | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| PE20081755A1 (es) | Nuevas 2-aminooxazolinas como ligandos taar1 | |
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| EA201070698A1 (ru) | Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| PE20070370A1 (es) | Compuestos derivados de carboxamidas como agentes fungicidas | |
| PE20081596A1 (es) | Derivados fluorinados de deferiprona | |
| UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| EA200901573A1 (ru) | Гетероарилзамещенные тиазолы | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| PE20060937A1 (es) | Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2) | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
| AR074353A1 (es) | Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatititis atopica. | |
| ATE552246T1 (de) | Substituierte aryloxy-n- bicyclomethylacetamidverbindungen als vr1- antagonisten | |
| PE20050293A1 (es) | Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos | |
| AR061185A1 (es) | Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |